TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
SPI1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with Lzr-PU.1ert2, treated 24hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
CD4+ T-cells |
Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks |
Permissive
|
Mus musculus |
GSE99165
...
|
MA0080.5
|
SPI1 |
GM12878 (female B-cells lymphoblastoid cell line) |
Characteristic: robotic ChIP-seq; |
Permissive
Robust
|
Homo sapiens |
GSE53366
...
|
MA0080.5
|
SPI1 |
neutrophils derived from immortalized progenitors |
Treatment: unstimulated; Strain: MRP8-Cre-ires/GFP (PU.1 WT); Genotype: HoxER-PU.1; |
Permissive
Robust
|
Mus musculus |
GSE110863
...
|
MA0080.5
|
SPI1 |
neutrophils derived from immortalized progenitors |
Treatment: stimulated for 1 hour with Candida albicans (heat-inactivated); Strain: MRP8-Cre-ires/GFP (PU.1 WT); Genotype: HoxER-PU.1; |
Permissive
Robust
|
Mus musculus |
GSE110863
...
|
MA0080.5
|
SPI1 |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0080.5
|
SPI1 |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0080.5
|
SPI1 |
spleen + lymph nodes |
Strain: C57BL/6; Genotype: wildtype; Source: FACS-purified FO B cell; |
Permissive
Robust
|
Mus musculus |
GSE128166
...
|
MA0080.5
|
SPI1 |
MEL(mouse erythroleukemia cells) |
Time: day0; Treatment: none; |
Permissive
Robust
|
Mus musculus |
GSE67955
...
|
MA0080.5
|
SPI1 |
MEL(mouse erythroleukemia cells) |
Time: day5; Treatment: 2% DMSO (VWR) added to the medium; |
Permissive
Robust
|
Mus musculus |
GSE67955
...
|
MA0080.5
|
Showing 10 records in page 819
from 963 pages